SCHEMBL25112911

SCHEMBL25112911

c1cnc2c(c1)ccc1ccc(-c3c4ccccc4c(-c4ccc(-c5cc6cccc7c8cccc9ccc%10cccc(c%11cccc5c%11c67)c%10c98)cc4)c4ccccc34)nc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 5/20 0.37
▸ CCR8 P51685 5/20 0.37
▸ CCR5 P51681 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ TDP1 Q9NUW8 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ GMNN O75496 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ MMP8 P22894 1/20 0.37
▸ THPO P40225 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25112798 0.91 CCR1 (0.37) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL25112979 0.88 CCR1 (0.37) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL25112946 0.88 CCR1 (0.41) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL24475245 0.87 CYP11B1 (0.48) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL25112799 0.86 CCR1 (0.40) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL25112874 0.86 CCR1 (0.39) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL12954935 0.85 CCR1 (0.43) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL25112816 0.84 CCR1 (0.47) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL25112978 0.82 CCR1 (0.41) CCR1CCR8CCR5MAPTSMN1; SMN2
SCHEMBL20456936 0.81 CCR1 (0.47) CCR1CCR8CCR5MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 CCR1 1810/4885CCR8 3519/4885CCR5 3362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback